Neuroimaging in Alzheimer disease: an evidence-based review (Q30844900)

27 June 2017

1 reference

title

Neuroimaging in Alzheimer disease: an evidence-based review (English)

1 reference

27 June 2017

0 references

1 reference

2

1 reference

27 June 2017

1

Kejal Kantarci

2 references

ORCID Public Data File 2021

27 June 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

Neuroimaging clinics of North America

27 June 2017

1 reference

27 June 2017

13

1 reference

27 June 2017

197-209

1 reference

27 June 2017

2

1 reference

Is the incidence of dementing illness changing? A 25-year time trend study in Rochester, Minnesota (1960-1984)

27 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

The prevalence of dementia is changing over time in Rochester, Minnesota

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

"Preclinical" AD revisited: neuropathology of cognitively normal older adults.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Memory and mental status correlates of modified Braak staging.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Clinico-neuropathological correlation of Alzheimer's disease in a community-based case series.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Multicenter clinicopathological correlation in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Clinical-neuropathological correlations in Alzheimer's disease and related dementias.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

A clinicopathological comparison of community-based and clinic-based cohorts of patients with dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Reliability and Validity of NINCDS-ADRDA Criteria for Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

The validity of 3 clinical diagnostic criteria for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

The role of routine laboratory studies and neuroimaging in the diagnosis of dementia: a clinicopathological study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Clinical diagnosis of Alzheimer's disease and other dementias in a population survey. Agreement and causes of disagreement in applying Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition, Criteria.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Standardization of the diagnosis of dementia in the Canadian Study of Health and Aging.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Cross-national interrater agreement on the clinical diagnostic criteria for dementia. WHO-PRA Age-Associated Dementia Working Group, WHO-Program for Research on Aging, Health of Elderly Program.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

MR‐based hippocampal volumetry in the diagnosis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Neuropathological stageing of Alzheimer-related changes

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Evaluation of dementia: a systematic study of the usefulness of the American Academy of Neurology's practice parameters

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Relationship between clinical and radiological diagnostic criteria for Alzheimer's disease and the extent of neuropathology as reflected by 'stages': a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Temporal lobe magnetic resonance imaging can differentiate Alzheimer's disease from normal ageing, depression, vascular dementia and other causes of cognitive impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Volumes of the entorhinal and perirhinal cortices in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

MRI of the hippocampus in Alzheimer's disease: sensitivity, specificity, and analysis of the incorrectly classified subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

The diagnostic value of SPECT with Tc 99m HMPAO in Alzheimer's disease: a population-based study.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Diagnosing Alzheimer's disease in elderly, mildly demented patients: the impact of routine single photon emission computed tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Brain blood flow in the dementias: SPECT with histopathologic correlation in 54 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Regional HmPAO SPECT and CT measurements in the diagnosis of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

SPECT perfusion imaging in the diagnosis of Alzheimer's disease: a clinical-pathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Interpretation variability of 18FDG-positron emission tomography studies in dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Probable Alzheimer disease: diagnosis with proton MR spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Mild cognitive impairment and Alzheimer disease: regional diffusivity of water

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Memory function in very early Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Mild cognitive impairment: clinical characterization and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Hippocampal formation glucose metabolism and volume losses in MCI and AD.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Regional magnetization transfer ratio changes in mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Preclinical prediction of Alzheimer's disease using SPECT.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

(1)H-MR spectroscopy differentiates mild cognitive impairment from normal brain aging.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)H MRS study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Clinical and pathological correlates of apolipoprotein E ?4 in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

APOE-epsilon4 is associated with less frontal and more medial temporal lobe atrophy in AD.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E epsilon 4 allele

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease: power calculations and estimates of sample size to detect treatment effects.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Serial magnetic resonance imaging of cerebral atrophy in preclinical Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Hippocampus in Alzheimer's disease: a 3-year follow-up MRI study.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Longitudinal decline of the neuronal marker N-acetyl aspartate in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Decrease of N-acetylaspartate in the MTL correlates with cognitive decline of AD patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer's disease. Pathophysiologic implications

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Longitudinal changes in cognitive function and regional cerebral function in Alzheimer's disease: a SPECT blood flow study.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Rates of hippocampal atrophy correlate with change in clinical status in aging and AD.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

Cost-effectiveness of functional imaging tests in the diagnosis of Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900025-X

7 January 2021

10.1016/S1052-5149(03)00025-X

Identifiers

DOI

1 reference

27 June 2017

1 reference

PubMed ID

13677801